Direktlink :
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4

The German Biotechnology Sector 2012

Die deutsche Biotech-Branche 2012 <ic:message key='Bild vergrößern' />

In 2011, the German biotechnology industry continued its moderate growth. . This is underlined by higher revenues of 2.6 billion euros (+10%), an increase in the number of employees to around 16,300 and a risen number of dedicated biotech firms (552).  Only a low sum of capital (142 million euro) was invested in the sector, and companies spent less money for research and development (R&D) and they have adapted their business models to the new conditions. These are the central findings of the company survey carried out at the beginning of 2012 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF).

The Biotechnology Sector

Summary

In 2011, the German biotechnology industry continued its moderate growth of recent years. This is underlined by higher revenues of 2.6 billion euros (+10%) and an increase in the number of employees to around 16,300 (+5.3%) in dedicated biotechnology firms. The number of dedicated biotechnology firms also rose (+2.6%). Research and development costs came to just under a billion euros in 2011 (-4%). Securing financing represented a major challenge for most biotechnology companies − a very low sum of just 142 million euros was invested in the sector over the course of the year.

Key figures of the biotech sector in GermanyLightbox-Link
Key figures of the biotech sector in GermanySource: biotechnologie.de

These are the central findings of the company survey carried out at the beginning of 2012 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF). All of the data are in compliance with the guidelines of the Organisation for Economic Cooperation and Development (OECD; see methodology). According to the survey, at 552, the number of companies occupied primarily with biotechnology in 2011 is slightly higher than 2010 (538). Unchanged remained the number of companies where biotechnology represents just one aspect of business activities. The biotech-related areas of these 126 companies counted a total of 17,570 employees. Thus, a total of around 33,900 staff are employed in the commercial biotechnology sector in Germany.

 
top

Context

The biotechnology company survey has been conducted by biotechnologie.de for the seventh time now. The time period over which the assessment has been carried out was January to March, 2012.  Out of the total 742 contacted firms,  584 participated in the survey – which is a response rate of 79 %. The cutoff date for the information included in the survey was 31.12.2011.          

Companies with their main focus predominantly or exclusively on biotechnology are classified as biotechnology companies. In this report they are referred to as dedicated biotech companies. Firms that are a majority-owned subsidiary of a non-German parent company but have a business address in Germany and perform R&D were also included.

This approach is orientated along the statistical guidelines of the Organisation for Economic Co-operation and Development (OECD) from 2004.

The use of all content is free of charge and is permitted only if the source (biotechnologie.de) is stated.

Downloads

Die deutsche Biotechnologie-Branche 2012

biotechnologie.de, April 2012. Deutsch/Englisch Download PDF (5.2 MB) View online

Die deutsche Biotechnologie-Branche 2011 

biotechnologie.de, April 2011. Deutsch/Englisch  Download PDF (2.8 MB) View online

Die deutsche Biotechnologie-Branche 2010

biotechnologie.de, April 2010. Deutsch/Englisch Download PDF (3.2 MB) View online